IRIS
PIZZIGALLO, Eligio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.371
AS - Asia 4.840
EU - Europa 4.797
SA - Sud America 851
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 16.948
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.256
SG - Singapore 1.754
CN - Cina 1.439
UA - Ucraina 947
IE - Irlanda 689
BR - Brasile 688
GB - Regno Unito 648
TR - Turchia 611
RU - Federazione Russa 568
VN - Vietnam 489
FR - Francia 427
SE - Svezia 419
IT - Italia 395
DE - Germania 368
FI - Finlandia 197
IN - India 196
BD - Bangladesh 95
AR - Argentina 78
CA - Canada 61
HK - Hong Kong 43
ID - Indonesia 34
MX - Messico 28
IQ - Iraq 27
PL - Polonia 24
ZA - Sudafrica 23
KR - Corea 22
AT - Austria 21
EC - Ecuador 21
ES - Italia 21
CZ - Repubblica Ceca 20
JP - Giappone 16
PK - Pakistan 16
CL - Cile 14
CO - Colombia 13
UZ - Uzbekistan 13
BE - Belgio 12
PY - Paraguay 12
NL - Olanda 11
TN - Tunisia 11
VE - Venezuela 11
EU - Europa 10
IL - Israele 9
MA - Marocco 9
SA - Arabia Saudita 9
JO - Giordania 8
LT - Lituania 8
MY - Malesia 8
PE - Perù 8
EG - Egitto 7
GR - Grecia 6
IR - Iran 6
JM - Giamaica 6
KE - Kenya 6
NP - Nepal 6
PH - Filippine 6
AU - Australia 5
AZ - Azerbaigian 5
CH - Svizzera 5
ET - Etiopia 5
BG - Bulgaria 4
CR - Costa Rica 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
GE - Georgia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
SC - Seychelles 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
NG - Nigeria 2
PS - Palestinian Territory 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GD - Grenada 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SR - Suriname 1
Totale 16.948
Salva come PNG Salva come JPEG
Città #
Singapore 1.287
Jacksonville 1.034
San Jose 763
Dublin 688
Chandler 580
Southend 557
Princeton 351
Izmir 340
Dallas 322
Nanjing 321
Ashburn 306
Beijing 267
Wilmington 191
Cambridge 171
Ho Chi Minh City 165
Santa Clara 156
Tongling 143
Los Angeles 141
The Dalles 132
Council Bluffs 129
Nanchang 119
Dearborn 114
Hanoi 110
Buffalo 105
Moscow 102
Altamura 99
Ann Arbor 76
São Paulo 66
Boardman 63
Kunming 58
Munich 58
Woodbridge 58
Shenyang 54
Grevenbroich 52
New York 52
Tianjin 42
Hebei 41
Jiaxing 35
Hong Kong 34
Toronto 32
Pune 28
Milan 27
Norwalk 27
Changsha 26
Hangzhou 25
Houston 24
Chieti 23
Haiphong 23
Brooklyn 21
Lanzhou 21
Augusta 20
Da Nang 20
Seoul 20
Brno 18
Rome 18
San Mateo 18
Orem 17
Rio de Janeiro 17
Chicago 16
Hefei 16
Helsinki 16
Tokyo 16
Denver 15
London 15
Redondo Beach 14
Atlanta 13
Belo Horizonte 13
Biên Hòa 13
Tashkent 13
Warsaw 13
Andover 12
Curitiba 12
Jinan 12
Nuremberg 12
San Francisco 12
Turku 12
Vienna 12
Brussels 11
Changchun 11
Johannesburg 11
Manchester 11
Phoenix 11
Recife 11
Stockholm 11
Brasília 10
Chennai 10
Fortaleza 10
Mexico City 10
Montreal 10
Mumbai 10
Salvador 10
Boston 9
Campinas 9
Orange 9
Radomsko 9
Seattle 9
Washington 9
Asunción 8
Baghdad 8
Can Tho 8
Totale 10.289
Salva come PNG Salva come JPEG
Nome #
Caso clinico di endoplastite da Staphylococcus capitis. 176
Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C-virus infection and non-alcoholic fatty liver disease. 176
Associations between hypertriglyceridemia and serum ghrelin, adiponectin, and IL-18 levels in HIV-infected patients. 171
HPV e displasie della cervice uterina: ricerca dell'HPV-DNA con PCR e correlazioni con l'esame citologico, colposcopico e istobioptico 162
Acute urinary retention due to HSV-1: a case report 158
La sindrome di Waterhouse-Friderichsen quale complicanza fatale nel bambino febbrile: descrizione di due casi clinici. 156
Metabolic modifications in HIV-infected women 152
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 150
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha 149
Alterations in muscles of CFS patients at morphological. biochemical and molecular level. 145
Cytomegalovirus infection in heart-transplants recipients, in a central region of Italy 143
Autoimmunità nelle epatiti croniche in terapia con IFN-alfa 139
Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. 138
Valutazione della sindrome da fatica cronica mediante A.B.R.: risultati preliminari 137
Ricerca con PCR e genotipizzazione dell'HPVDNA in donne con dispiasia della cervice uterina e nei loro partner 137
Could S-100b be a marker of the neurologic involvement in HIV-affected patients? 137
Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. 137
Efficacia clinica del trattamento intravescicale con BCG per neoplasie vescicali superficiali in rapporto alla risposta immunitaria indotta. 136
Cystatin C, adipokines and cardiovascular risk in HIV infected patients. 133
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 133
Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. 131
Ricerche sull'autoimmunità in alcune epatopatie. 131
Economic evaluation on HIV treatments: The I.Co.N.A. cohort study. 130
Insights the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients 129
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 126
I potenziali evocati uditivi troncoencefalici nella valutazione della Sindrome da Fatica Cronica. 125
Psychiatric diagnosis and comorbidity and chronic fatigue syndrome 123
Interruption of highly active antiretroviral therpy in HIV clinical practice. 123
Quality of life, depression and cytokine patterns in patients with chronic hepatitis C treated with antiviral therapy. 122
Viral interference between hepatitis B, C and D viruses in dual and triple infections in HIV-positive patients. 122
Is moderate HIV-viremia associated with a higher risk of clinical progression in HIV-infected people treated with high active antiretroviral therapy. 122
Treatment with silibyn- Vitamin E- Phospholipid complex in patients with Hepatitis C infection. 121
Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center 120
A leukemic patient with hepatosplenic abscesses due to coagulase-negative staphylococci. 120
Interleukin-4 and interferon-gamma production during HIV-1 infection and changes induced by antiretroviral therapy. 120
Inguinal lymphadenopathy due to Bartonella henselae 120
Ricerca degli anticorpi fissanti il complemento contro il virus dell'herpes simplex (ed altri virus neurotropi) in pazienti con sclerosi multipla. 120
Effetti del trattamento con vitamina e sulla sintomatologia muscoloscheletrica soggettiva ed oggettiva della sindrome da fatica cronica 120
Neurite acistica bilaterale HIV-correlata: descrizione di un caso ad evoluzione favorevole in seguito a terapia antiretrovirale. 119
Acquired immunodeficiency without HIV infection: epidemiology and clinical autcome in Italy. 119
Hepatitis C virus infection and myositis: a virus localization study. 119
Usefulness of Leifson staining method in diagnosis of Helicobacter pylori infection. 119
Nuovi aspetti della terapia antibiotica associata (rassegna critica e contributo personale). 118
Vertical transmission of hepatitis C virus: an epidemiological study on 2,980 pregnant women in Italy. 117
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. 116
The association of chronic hepatitis B and myopathy 115
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. 115
Epatite virale B e polimiosite. Descrizione di un caso di polimiosite associato ad epatite virale B. 114
Short communication: Proangiogenic hematopoietic cells in acute HIV infection 114
Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. 114
L'immunità cellulare nelle epatopatie: stimolazione in vitro dei linfociti con antigeni epatici. 113
Peripheral blood mononuclear cell beta-endorphin concentration is decreased in chronic fatigue syndrome and fibromyalgia but not in depression: preliminary report 113
MR imaging in the clinical diagnosis of chronic fatigue syndrome (CFS). 112
Circadian variations of prolactine (PRL), thyreotropic hormone (TSH), adrenocorticotropic hormone (ACTH) and cortisol (CS) in the chronic fatigue syndrome (CFS). 111
High dose of erythropoietin in management of interferon/ribavirin induced anemia 111
Proteinuria in an African HIV-infected patient: effects of telmisartan. 111
Methicillin-resistant staphylococcus epidermidis (MRSE) endocarditis treated with linezolid 110
Ocular manifestations in chronic fatigue syndrome. 110
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 109
Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome 109
Predictability of sustained virological response to pegylate interferon alpha-2b plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C infection. 109
An unusual complication of brucellosis: hepatic abscess. 108
Multicentre study on the prevalence of symptoms and symptomatic treatment in HIV infection. 108
b-endorphin concentrations are decreased in peripheral blood mononuclear cells of chronic fatigue syndrome patients: comparison with depression. 107
Valutazione comparativa delle tecniche di immunodiffusione su agar e counter-elettroforesi nella ricerca dell'antigene Australia. 105
Ulteriori osservazioni sul sistema HBeAg-HBeAb in corso di epatite ed in portatori di HBsAg. 105
Mortality from HIV and TB coinfections in higher in Eastern Europe than in Western Europe and Argentina. 104
Improved metabolic profile after switch to darunavir/ritonavir in HIV positive patients previously on protease inhibitor therapy. 104
Patient-reported and Physician-estimated Adherence to HAART. 103
Metabolic syndrome and cardiovascular risk in HIV-infected patients with lipodystrophy. 102
Granulomatous cheilitis in an HIV positive patient on HAART Therapy. 102
The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora. 101
Le associazioni di antibiotici: aspetti clinici. 101
Attualità sulle infezioni batteriche del SNC. 100
Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression 100
Increased production of oncostatin-M by lymphomononuclear cells from HIV-1-infected patients with neuroAIDS. 99
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing. 99
Use of hematopoietic growth factor in the management of hematological side effects associated to antiviral treatment for HCV hepatitis. 98
Study of immune alterations in patients with Chronic Fatigue Syndrome to reach a better nosografic and pathogenetic characterization of subgroups with different etiologies. 97
Chronic fatigue syndrome following a toxic exposure. 97
Risk of developing specific AIDS-defining illness in patients coinfected with HIV and hepatitis C virus with or without cirrhosis. 97
Research on a new hepatitis B antigen-antibody system: e- anti-e. 97
Antiretroviral therapy in HIV-infected individuals in clinical practice: are the criteria for initiating and choosing the type of drug regimen based only on immunologic and virologic values? 97
An Italian study on health-related quality of life and fatigue in patients with chronic fatigue syndrome and patients with chronic HCV virus infection: similarities and differences 96
Ricerca dell'anticorpo contro il virus A (=HAAb) per l'epidemiologia e la diagnosi dell'epatite A. 94
Inflammatory cytokines and S-100b protein in patients with hepatitis C infection and cryoglobulinemias 91
A case report of a new inflammatory eye syndrome in an HIV positive patient: the immune restoration uveitis. 91
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 89
Relationship between HAART adherence and adipose tissue alterations. 89
Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome 89
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART. 88
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 87
Chromatographic and electrophoretic studies of immune complexes in non-A, non-B hepatitis. 87
Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures. 87
Modelling the 3-year risk of myocardial infarction among participants in the data collection on adverse events of anti-HIV drugs (DAD) study. 87
Clinical and Pathophysiological Aspects of Chronic Fatigue Syndrome 87
Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. 87
Comparative analysis of two systems for HCV genotyping. 86
Submaximal aerobic exercise with mechanical vibrations improves the functional status of patients with Chronic Fatigue Sindrome. 86
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment out come in Italian chronically HCV-infected patients. 86
Totale 11.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.845
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 0 35
2021/2022597 7 3 5 103 47 12 11 68 52 13 85 191
2022/20231.921 206 271 112 187 178 404 136 112 226 18 27 44
2023/2024708 58 27 34 18 33 205 238 19 0 6 5 65
2024/20252.757 216 579 468 33 21 48 7 145 228 138 270 604
2025/20265.134 409 296 691 789 321 293 727 414 463 403 235 93
Totale 17.175